Changes in Otoacoustic Emissions and Auditory Brain Stem Response after C/s‐Platinum Exposure in Gerbils
- 1 June 1997
- journal article
- Published by Wiley in Otolaryngology -- Head and Neck Surgery
- Vol. 116 (6), 585-592
- https://doi.org/10.1016/s0194-5998(97)70232-8
Abstract
Ototoxicity associated with cis-platinum administration commonly presents as hearing loss and tinnitus. The hearing loss is usually an irreversible, high-frequency sensorineural loss. Histologic studies in humans and animals suggest that the outer hair cells (OHCs) are most susceptible to cis-platinum. Evoked otoacoustic emissions (EOAE), as a measure of outer hair cell function, are potentially useful in following ototoxic insults involving OHCs. Distortion-product otoacoustic emissions (DPOAE) test frequency-specific regions of the cochlea and therefore may be particularly well suited for monitoring ototoxic injuries. We measured distortion product otoacoustic emissions, at f2 = 2, 4, 6, 8, 10, and 12 kHz, in gerbils after a single large dose of cis-platinum. Animals treated with saline served as controls. The findings were compared to auditory brain stem evoked response (ABR) thresholds, using tone pips of the same frequencies. The DPOAE and ABR thresholds were measured before treatment and again 2, 5, and 14 days after drug administration. The changes in DPOAE were compared with the changes in ABR. No treatment effect was noted in the 2-day group. Animals treated with c/s-platinum demonstrated significant elevation of DPOAE and ABR thresholds compared with control animals at 5 and 14 days. There was no significant difference between the threshold changes in the 5-and 14-day groups.Keywords
This publication has 27 references indexed in Scilit:
- Cis‐platinum ototoxicity in childrenThe Laryngoscope, 1991
- Cis‐Platinum ototoxicity in childrenThe Laryngoscope, 1991
- The behavior of the acoustic distortion product, 2f1−f2, from the human ear and its relation to auditory sensitivityThe Journal of the Acoustical Society of America, 1990
- High‐Dose cisplatin treatment: Hearing loss and plasma concentrationsThe Laryngoscope, 1990
- The Clinical Utility of Distortion-Product Otoacoustic EmissionsEar & Hearing, 1990
- Ototoxicity of high‐dose cisplatin by bolus administration in patients with advanced cancers and normal hearingThe Laryngoscope, 1988
- Ototoxicity of low- and moderate-dose cisplatinCancer, 1985
- Cis-Diaminedichloro Platinum Ototoxicity: An Experimental StudyActa Oto-Laryngologica, 1985
- Cis‐platinum Ototoxicity: Clinical experience and temporal bone histopathologyThe Laryngoscope, 1983
- Inner ear histopathology in patients treated with Cis‐Platinum.The Laryngoscope, 1982